Fantastic news today as children with leukaemia will be able to access CAR-T therapy on the NHS. The CAR-T cells in this pilot have been derived from peripheral blood. Groups are working on the same process using CAR-T cells from umbilical cord blood, a non-invasive source of therapeutic cells. Biovault’s Shaun Mansfield, a stem cell scientist specialising in umbilical cord cells says: “We’re delighted at this step forward in cell-based therapies.”
Children with leukaemia to receive CAR-T therapy on the NHS
Let's get you started
Cord blood processing and storage for families. Choose a 10 or 25 storage period and reduced fees for twins.
Cord blood and tissue storage for families wishing to store stem cell-rich umbilical tissue as well as cord blood.